S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7124 +0.21%
PRE-MKT · 08:30 ET
Market ClerkRecap
Thu Oct 22 · pre-market6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

RXRX

RECURSION PHARMACEUTICALS, INC.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
3.64
−0.02 −0.55%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.9BP/E —DIV YIELD —FCF YIELD -18.08%REV TTM $54.9M −15.1%NET INCOME −$518.9MNET CASH $545M52W 2.84 – 6.30NEXT EARNINGS Nov 4 EST.SEC XBRL · TTM TO Invalid Date

What RXRX had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 15Material agreementResults announcedOther eventReg FD disclosureOct 15open on EDGAR ↗
Sep 21Material agreementSep 15open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch RXRX. Know when insiders buy.
One email the day a filing lands. Free.